Publicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (24)

2024

  1. Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: a retrospective cohort study

    Journal of Gastrointestinal Oncology, Vol. 15, Núm. 3, pp. 1072-1081

  2. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Adult height and risk of gastric cancer: A pooled analysis within the Stomach cancer Pooling Project

    European Journal of Cancer Prevention, Vol. 32, Núm. 3, pp. 215-221

  2. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)

    Nature Genetics

  3. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

    Nature Genetics, Vol. 55, Núm. 1, pp. 89-99

  4. Leisure-time physical activity and gastric cancer risk: A pooled study within the Stomach cancer Pooling (StoP) Project

    PloS one, Vol. 18, Núm. 7, pp. e0286958

2022

  1. Coffee consumption and gastric cancer: A pooled analysis from the Stomach cancer Pooling Project consortium

    European Journal of Cancer Prevention, Vol. 31, Núm. 2, pp. 117-127

2021

  1. Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: A Mendelian randomization study

    American Journal of Clinical Nutrition, Vol. 113, Núm. 6, pp. 1490-1502

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Response to Li and Hopper

    American Journal of Human Genetics

2020

  1. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study

    BMC Medicine, Vol. 18, Núm. 1

  2. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses

    Gastroenterology, Vol. 158, Núm. 5, pp. 1300-1312.e20

  3. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses

    BMC medicine, Vol. 18, Núm. 1, pp. 229

  4. Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer

    Gastroenterology, Vol. 158, Núm. 5, pp. 1274-1286.e12

  5. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk

    American Journal of Human Genetics, Vol. 107, Núm. 3, pp. 432-444

  6. Meat intake and risk of gastric cancer in the Stomach cancer Pooling (StoP) project

    International Journal of Cancer, Vol. 147, Núm. 1, pp. 45-55

  7. Mendelian randomization of circulating polyunsaturated fatty acids and colorectal cancer risk

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 4, pp. 860-870

2019

  1. Correction to: Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer (Human Genetics, (2019), 138, 4, (307-326), 10.1007/s00439-019-01989-8)

    Human Genetics

  2. Discovery of common and rare genetic risk variants for colorectal cancer

    Nature Genetics, Vol. 51, Núm. 1, pp. 76-87

  3. Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer

    Human Genetics, Vol. 138, Núm. 4, pp. 307-326